語系:
繁體中文
English
日文
簡体中文
說明(常見問題)
登入
回首頁
到查詢結果
[ subject:"Drug development" ]
切換:
標籤
|
MARC模式
|
ISBD
Significant pharmaceuticals reported...
~
DeRosa, Thomas F.
Significant pharmaceuticals reported in recent US patents[electronic resource] /
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
杜威分類號:
615.1900973
書名/作者:
Significant pharmaceuticals reported in recent US patents/ Thomas F. DeRosa.
作者:
DeRosa, Thomas F.
出版者:
Amsterdam ; : Elsevier,, 2007.
面頁冊數:
xx, 680 p. : : ill. ;; 25 cm.
附註:
Includes index.
標題:
Drugs - Research - United States.
標題:
Drugs - Patents. - United States
標題:
Drug development - United States.
ISBN:
9780080453446
ISBN:
0080453449
內容註:
Acquired Immune Deficiency Syndrome -- Addiction Disorders -- Alzheimer's Disease -- Analgesics -- Antibacterial Agents -- Anti-inflammatory Agents -- Autoimmune Disorders -- Cardiovascular Disorders -- Diabetes -- Diagnostics -- Epilepsy -- Gastrointestional Disorders -- Hepatitis C -- Hormonal Disorders -- Immunosuppressants -- Improved Synthetic Methods -- Incontinence -- Irritable Bowel Syndrome -- Osteoporosis -- Malaria -- Migraine Headaches -- Obesity -- Proliferative Disorders -- Skin Disorders -- Sleep Disorders -- Thyroid Disorders -- Tinnitus.
摘要、提要註:
This book identifies the next generation of pharmaceuticals reported in US Patents. This "hands-on" title provides explicit laboratory methods for preparing the most recent and effective medications. Each entry documents the biological testing protocols used to evaluate a drug and the significance of the current treatment agent over previous methods. Pharmaceuticals are included in this review only if at least two of the following criteria were met: Effectiveness in treating an illness, Innovative, ease of preparation, synergy with existing Medications. Pharmaceuticals are reported for 27 separate classes of illness, including; AIDS, Alzheimer's Disease, Cardiovascular Disorders, Diabetes, Epilepsy, Hepatitis C, Osteoporosis, Obesity and Sleep Disorders. Significant Pharmaceuticals Reported in US Patents has been designed to be used as both a reference and synthetic guide for pharmaceutical, medicinal and organic chemists and graduate students. Researchers working in other areas will also find the information valuable as in many instances intermediates or the next generation pharmaceutical are readily convertible into other industrial products including: anti-oxidants, chemical additives, herbicides, polymer precursors, water purification agents. Clear structural depictions of reagents and chemical transformations have been supplied to permit the identification of other future applications. * Identifies next generation pharmaceuticals * Provides practical preparation methods for each active agent and derivatives * Documents the analytical characterization and biological testing results of active agents.
電子資源:
An electronic book accessible through the World Wide Web; click for information
Significant pharmaceuticals reported in recent US patents[electronic resource] /
DeRosa, Thomas F.
Significant pharmaceuticals reported in recent US patents
[electronic resource] /Thomas F. DeRosa. - Amsterdam ;Elsevier,2007. - xx, 680 p. :ill. ;25 cm.
Includes index.
Acquired Immune Deficiency Syndrome -- Addiction Disorders -- Alzheimer's Disease -- Analgesics -- Antibacterial Agents -- Anti-inflammatory Agents -- Autoimmune Disorders -- Cardiovascular Disorders -- Diabetes -- Diagnostics -- Epilepsy -- Gastrointestional Disorders -- Hepatitis C -- Hormonal Disorders -- Immunosuppressants -- Improved Synthetic Methods -- Incontinence -- Irritable Bowel Syndrome -- Osteoporosis -- Malaria -- Migraine Headaches -- Obesity -- Proliferative Disorders -- Skin Disorders -- Sleep Disorders -- Thyroid Disorders -- Tinnitus.
This book identifies the next generation of pharmaceuticals reported in US Patents. This "hands-on" title provides explicit laboratory methods for preparing the most recent and effective medications. Each entry documents the biological testing protocols used to evaluate a drug and the significance of the current treatment agent over previous methods. Pharmaceuticals are included in this review only if at least two of the following criteria were met: Effectiveness in treating an illness, Innovative, ease of preparation, synergy with existing Medications. Pharmaceuticals are reported for 27 separate classes of illness, including; AIDS, Alzheimer's Disease, Cardiovascular Disorders, Diabetes, Epilepsy, Hepatitis C, Osteoporosis, Obesity and Sleep Disorders. Significant Pharmaceuticals Reported in US Patents has been designed to be used as both a reference and synthetic guide for pharmaceutical, medicinal and organic chemists and graduate students. Researchers working in other areas will also find the information valuable as in many instances intermediates or the next generation pharmaceutical are readily convertible into other industrial products including: anti-oxidants, chemical additives, herbicides, polymer precursors, water purification agents. Clear structural depictions of reagents and chemical transformations have been supplied to permit the identification of other future applications. * Identifies next generation pharmaceuticals * Provides practical preparation methods for each active agent and derivatives * Documents the analytical characterization and biological testing results of active agents.
Electronic reproduction.
Amsterdam :
Elsevier Science & Technology,
2007.
Mode of access: World Wide Web.
ISBN: 9780080453446
Source: 133781:133907Elsevier Science & Technologyhttp://www.sciencedirect.comSubjects--Topical Terms:
431359
Drugs
--Research--United States.Index Terms--Genre/Form:
336502
Electronic books.
LC Class. No.: RM301.25 / .D47 2007
Dewey Class. No.: 615.1900973
Significant pharmaceuticals reported in recent US patents[electronic resource] /
LDR
:03551cam 2200325Ia 4500
001
347574
003
OCoLC
005
20110615082928.0
006
m d
007
cr cn|||||||||
008
111130s2007 ne a o 001 0 eng d
020
$a
9780080453446
020
$a
0080453449
029
1
$a
NZ1
$b
11778308
035
$a
(OCoLC)162131457
035
$a
ocn162131457
037
$a
133781:133907
$b
Elsevier Science & Technology
$n
http://www.sciencedirect.com
040
$a
OPELS
$c
OPELS
$d
OPELS
049
$a
TEFA
050
1 4
$a
RM301.25
$b
.D47 2007
082
0 4
$a
615.1900973
$2
22
100
1
$a
DeRosa, Thomas F.
$3
403653
245
1 0
$a
Significant pharmaceuticals reported in recent US patents
$h
[electronic resource] /
$c
Thomas F. DeRosa.
260
$a
Amsterdam ;
$a
London :
$b
Elsevier,
$c
2007.
300
$a
xx, 680 p. :
$b
ill. ;
$c
25 cm.
500
$a
Includes index.
505
0
$a
Acquired Immune Deficiency Syndrome -- Addiction Disorders -- Alzheimer's Disease -- Analgesics -- Antibacterial Agents -- Anti-inflammatory Agents -- Autoimmune Disorders -- Cardiovascular Disorders -- Diabetes -- Diagnostics -- Epilepsy -- Gastrointestional Disorders -- Hepatitis C -- Hormonal Disorders -- Immunosuppressants -- Improved Synthetic Methods -- Incontinence -- Irritable Bowel Syndrome -- Osteoporosis -- Malaria -- Migraine Headaches -- Obesity -- Proliferative Disorders -- Skin Disorders -- Sleep Disorders -- Thyroid Disorders -- Tinnitus.
520
$a
This book identifies the next generation of pharmaceuticals reported in US Patents. This "hands-on" title provides explicit laboratory methods for preparing the most recent and effective medications. Each entry documents the biological testing protocols used to evaluate a drug and the significance of the current treatment agent over previous methods. Pharmaceuticals are included in this review only if at least two of the following criteria were met: Effectiveness in treating an illness, Innovative, ease of preparation, synergy with existing Medications. Pharmaceuticals are reported for 27 separate classes of illness, including; AIDS, Alzheimer's Disease, Cardiovascular Disorders, Diabetes, Epilepsy, Hepatitis C, Osteoporosis, Obesity and Sleep Disorders. Significant Pharmaceuticals Reported in US Patents has been designed to be used as both a reference and synthetic guide for pharmaceutical, medicinal and organic chemists and graduate students. Researchers working in other areas will also find the information valuable as in many instances intermediates or the next generation pharmaceutical are readily convertible into other industrial products including: anti-oxidants, chemical additives, herbicides, polymer precursors, water purification agents. Clear structural depictions of reagents and chemical transformations have been supplied to permit the identification of other future applications. * Identifies next generation pharmaceuticals * Provides practical preparation methods for each active agent and derivatives * Documents the analytical characterization and biological testing results of active agents.
533
$a
Electronic reproduction.
$b
Amsterdam :
$c
Elsevier Science & Technology,
$d
2007.
$n
Mode of access: World Wide Web.
$n
System requirements: Web browser.
$n
Title from title screen (viewed on July 25, 2007).
$n
Access may be restricted to users at subscribing institutions.
650
0
$a
Drugs
$x
Research
$z
United States.
$3
431359
650
0
$a
Drugs
$z
United States
$x
Patents.
$3
431360
650
0
$a
Drug development
$z
United States.
$3
431361
655
7
$a
Electronic books.
$2
local
$3
336502
710
2
$a
ScienceDirect (Online service)
$3
365609
776
1
$c
Original
$z
9780080453446
$z
0080453449
$w
(OCoLC)77540482
856
4 0
$3
ScienceDirect
$u
http://www.sciencedirect.com/science/book/9780080453446
$z
An electronic book accessible through the World Wide Web; click for information
994
$a
C0
$b
TEF
筆 0 讀者評論
多媒體
多媒體檔案
http://www.sciencedirect.com/science/book/9780080453446
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼
登入